Loading...
AI-Driven Vaccine Partnerships And Dark Genome Targets Will Shape Long-Term Opportunity
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
1Y
33.2%7D
-8.0%1Y
33.2%7D
-8.0%You can edit this narrative until Dec 16 11:05 AM. Then, changes will post as Updates.